Evaluation of Bleeding Score in Egyptian Patients With vWD Type I and Correlate it With Laboratory Parameters
NCT03915873 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2019-09-10
Summary
Applying the ISTH-BAT questionnaire on Egyptian patients with type I VWD aiming to correlate the BS with the laboratory findings
Conditions
- Von Willebrand Disease, Type 1
Interventions
- DIAGNOSTIC_TEST
-
The von Willebrand Antigen level
blood sample
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2020-12-01
- Completion
- 2021-03-01
More Related Trials
-
Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
NCT02792205 ·Status: COMPLETED
-
World Bleeding Disorders Registry Pilot Study
NCT02776826 ·Status: COMPLETED
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
NCT06610201 ·Status: RECRUITING
-
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
NCT04106323 ·Status: UNKNOWN
-
The Von Willebrand Disease (VWD) International Prophylaxis Study
NCT00557908 ·Status: COMPLETED
-
Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
NCT02324517 ·Status: UNKNOWN
-
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
NCT04106908 ·Status: ACTIVE_NOT_RECRUITING
-
Real-life Data of Constitutional Von Willebrand Disease in Western France
NCT04887324 ·Status: COMPLETED
-
Gingival Bleeding and Von Willebrand Disease Typ 2 and 3
NCT03078595 ·Status: COMPLETED
-
Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
NCT00004667 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
NCT01410227 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age
NCT04953884 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
NCT00816660 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy
NCT00683189 ·Status: COMPLETED ·Phase: NA
-
Von Willebrand Factor in Pregnancy (VIP) Study
NCT04146376 ·Status: RECRUITING
-
A Study With OPTIVATE® in People With Von Willebrand Disease
NCT00387192 ·Status: TERMINATED ·Phase: PHASE3
-
National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
NCT00510042 ·Status: COMPLETED
-
ATHN 9: Severe VWD Natural History Study
NCT03853486 ·Status: ACTIVE_NOT_RECRUITING
-
Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
NCT04657887 ·Status: COMPLETED
-
Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A
NCT02954575 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
NCT00168090 ·Status: COMPLETED ·Phase: PHASE4
-
What is the Feasibility of the ISTEP Exercise Test in Boys With Haemophilia
NCT04076306 ·Status: COMPLETED ·Phase: NA
-
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
NCT05776069 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Genetic Background of Patients With Low Von Willebrand Factor Levels
NCT05116501 ·Status: UNKNOWN ·Phase: NA